Hamilton Lane Advisors’s Guardant Health GH Stock Holding History

Hamilton Lane Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,660	Closed	-$382K	–	39
2023 Q2	$382K	Hold	10,660	–	–	0.17%	42
2023 Q1	$250K	Hold	10,660	–	–	0.08%	52
2022 Q4	$290K	Hold	10,660	–	–	0.1%	52
2022 Q3	$574K	Hold	10,660	–	–	0.21%	41
2022 Q2	$430K	Hold	10,660	–	–	0.17%	47
2022 Q1	$706K	Hold	10,660	–	–	0.16%	47
2021 Q4	$1.07M	Hold	10,660	–	–	0.14%	56
2021 Q3	$1.33M	Hold	10,660	–	–	0.22%	41
2021 Q2	$1.32M	Hold	10,660	–	–	0.41%	45
2021 Q1	$1.63M	Sell	10,660 -23,644	-69%	-$3.57M	0.53%	40
2020 Q4	$4.42M	Hold	34,304	–	–	1.65%	13
2020 Q3	$3.83M	Hold	34,304	–	–	1.85%	12
2020 Q2	$2.78M	Hold	34,304	–	–	1.49%	15
2020 Q1	$2.39M	Sell	34,304 -84,615	-71%	-$6.49M	1.38%	15
2019 Q4	$9.29M	Sell	118,919 -72,470	-38%	-$5.22M	4.08%	5
2019 Q3	$12.2M	Buy	+191,389	New	+$16.9M	5.11%	4

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hamilton Lane Advisors's GH Position: Q3 2023 in Review

Hamilton Lane Advisors sold out of Guardant Health (GH) in Q3 2023, closing a stake of 10,660 shares — an estimated $382K sold.

Hamilton Lane Advisors first reported a position in GH in Q3 2019 and held it in 16 quarters. The position peaked at $12.2M in Q3 2019. 296 funds tracked by Wall St. Rank hold GH as of Q3 2023.

Hamilton Lane Advisors reported no remaining Guardant Health position as of Q3 2023 after selling out during the quarter.
Hamilton Lane Advisors sold 10,660 Guardant Health shares in Q3 2023, an estimated $382K.
Hamilton Lane Advisors first reported a position in Guardant Health in Q3 2019 and held it in 16 quarters.
Hamilton Lane Advisors's Guardant Health position peaked at $12.2M in Q3 2019.
296 funds tracked by Wall St. Rank held Guardant Health as of Q3 2023.

Based on Hamilton Lane Advisors's 13F filing for Q3 2023, filed 7 Nov 2023.